John Z. Liang
John Z. Liang has a total of 36 co-authors. Here are the top co-authors by number of shared publications:
- Daniel A. Scott
Vaccine Research and Development, Pfizer Inc, Collegeville, PA, USA
3 shared publications - Alejandra Gurtman
Pfizer Vaccines, Pfizer Inc., Pearl River, NY 10965, USA
2 shared publications - Anna Roca
Medical Research Council Unit The Gambia at the London School of Hygiene and Tropical Medicine, Fajara, The Gambia
1 shared publication - Annaliesa S. Anderson
Pfizer Vaccine Research and Development
1 shared publication - Beate Kampmann
Vaccines and Immunity Theme, MRC Unit The Gambia at the London School of Hygiene and Tropical Medicine, Fajara, The Gambia
1 shared publication - Bubacarr Ceesay
Vaccines and Immunity, Medical Research Council Unit The Gambia, 6 Atlantic Road, Fajara 000273, Gambia
1 shared publication
Latest Publications
- Open Access
- 22 September 2023
- Published by Wolters Kluwer Health in The Pediatric Infectious Disease Journal
- Vol. 42 (12) , 1045-1050
A Longitudinal Study of Group A Streptococcal Colonization and Pharyngitis in US Children
Background: Group A streptococci (GAS) are a major cause of pharyngitis in children. Recently, there were severe GAS outbreaks. The aims of this study were to assess pharyngeal colonization prevalence in healthy children, to assess different diagnostic definitions for GAS pharyngitis and to estimate incidence rates for these infections. Methods: A 2-year longitudinal study was conducted in healthy children in the United States. Pharyngeal swabs were cultured every 3 months for GAS colonization. Serum antistreptolysin O, antideoxyribonuclease B (DNaseB) and antistreptococcal C5a peptidase (SCP) antibody titers were assessed at baseline. When participants developed a sore throat, pharyngeal swabs were collected for rapid antigen detection test (RADT) and culture, and antibody titers were determined in serum samples. A range of case definitions were used for GAS pharyngitis. Results: A total of 422 children 3–12 years old were enrolled (140, 141 and 141 were 3–5, 6–9 and 10–12 years of age, respectively). The overall prevalence of GAS colonization during the study was 48%. Baseline antistreptolysin O, anti-DNaseB and anti-SCP antibody titers were higher for children older than 5 years. The incidence of GAS pharyngitis per 100 person-years was 15.9 for RADT/culture-proven and 4.6 for serologically confirmed pharyngitis. Conclusions: GAS throat colonization and pharyngitis were frequent in children 3–12 years old. The case definition employed impacted the measured incidence of GAS pharyngitis, with higher rates detected using RADT/culture-based definitions. These data suggest that case definition is important and that young children are exposed to GAS, which may inform plans for vaccine development and implementation.
- 22 September 2023
- Published by Wolters Kluwer Health in The Pediatric Infectious Disease Journal
- Vol. 42 (12) , 1045-1050
Open AccessA Longitudinal Study of Group A Streptococcal Colonization and Pharyngitis in US Children
Background: Group A streptococci (GAS) are a major cause of pharyngitis in children. Recently, there were severe GAS outbreaks. The aims of this study were to assess pharyngeal colonization prevalence in healthy children, to assess different diagnostic definitions for GAS pharyngitis and to estimate incidence rates for these infections. Methods: A 2-year longitudinal study was conducted in healthy children in the United States. Pharyngeal swabs were cultured every 3 months for GAS colonization. Serum antistreptolysin O, antideoxyribonuclease B (DNaseB) and antistreptococcal C5a peptidase (SCP) antibody titers were assessed at baseline. When participants developed a sore throat, pharyngeal swabs were collected for rapid antigen detection test (RADT) and culture, and antibody titers were determined in serum samples. A range of case definitions were used for GAS pharyngitis. Results: A total of 422 children 3–12 years old were enrolled (140, 141 and 141 were 3–5, 6–9 and 10–12 years of age, respectively). The overall prevalence of GAS colonization during the study was 48%. Baseline antistreptolysin O, anti-DNaseB and anti-SCP antibody titers were higher for children older than 5 years. The incidence of GAS pharyngitis per 100 person-years was 15.9 for RADT/culture-proven and 4.6 for serologically confirmed pharyngitis. Conclusions: GAS throat colonization and pharyngitis were frequent in children 3–12 years old. The case definition employed impacted the measured incidence of GAS pharyngitis, with higher rates detected using RADT/culture-based definitions. These data suggest that case definition is important and that young children are exposed to GAS, which may inform plans for vaccine development and implementation.